일양약품우

007575KOSPIView the 제약 sectorTheme Bio & healthcare

7,180KRWMarket close of 10/21 (Wed)

Up +0.42%+30KRWMarket close of 10/21 (Wed)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/22 (Thu)7,040KRWDown -1.95%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open: 7,160
High: 7,180
Low: 7,020
Day range: Day range low 7,020 high 7,180, open 7,160, close 7,180, previous close 7,150
Volume: 0×10K shares
: 462,390 KRW 0.20× the 20-session average

Market close of 10/21 (Wed)

Where it sits in the 1-year range

3% of the way up from the lowest close in 1 year (252 sessions) · -53.8% from the high

Something to check

1 to check: operating loss

Free · no sign-inSource from 2021-05-17

Points to check

Earningsto check-5.8B KRWOperating income over the last four quarters -5.8B KRW (loss)Operating income, 8 quarters
Recent filingsnot verifiedOutside filing data coverage, so not verified
Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

Daily move+0.42%usual range
Trading value0.2×usual range
Data date10/21 (Wed)Market close

See the full check report

Key figures

: 3.2B KRW
: Not computed for preferred shares
: Not computed for preferred shares
: 445,080 shares
Trading value ratio: 0.20× the 20-session average0.2×

52-week closing rangeNow 7,180

6,88015,550

As of 2026-10-21 · KRX

Something to check

1 to check: operating loss

Earningsto checkQuarterly operating income bars (6); the four dark bars make up the sum-5.8B KRW
Recent filingsnot verifiedOutside filing data coverage, so not verified
Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
Daily moveusual range+0.42% on the reference date, placed against the usual ±1.34% band0.3×
Trading valueusual range0.20× the 20-session average0.2×
Data dateusual rangeMarket close data of 2026-10-21

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected

Revenue65.1B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
+5.0%
vs. prior quarter
-17.5%
Operating income-7.4B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
Turned to loss
vs. prior quarter
Turned to loss
Operating margin-11.3%Operating margin bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
-16.8 pp
vs. prior quarter
-12.0 pp

Quarterly operating income trend

2021Q1 8.2B KRW2026Q1 -7.4B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW

Same sector · top by trading value
Stock	20D	Change	Trading value
삼성바이오로직스	Close over the last 20 sessions +1.5%	Up +1.87%	166.1B KRW
셀트리온	Close over the last 20 sessions +9.6%	Up +0.10%	119.2B KRW
지투지바이오	Close over the last 20 sessions +27.6%	Up +13.78%	49.8B KRW
삼익제약	Close over the last 20 sessions -20.3%	Up +2.58%	47.2B KRW
유한양행	Close over the last 20 sessions +11.7%	Up +0.46%	35.3B KRW

Other share classes of this company · 일양약품

Schedule

Next data 10/23 (Fri) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.